A. E. Butler, J. Janson, S. Bonner-weir, R. Ritzel, R. A. Rizza et al., Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes, vol.52, pp.102-110, 2003.

M. Prentki and C. J. Nolan, Islet beta cell failure in type 2 diabetes, J Clin Invest, vol.116, pp.1802-1812, 2006.

G. C. Weir and S. Bonner-weir, Islet beta cell mass in diabetes and how it relates to function, birth, and death, Ann NY Acad Sci, vol.1281, pp.92-105, 2013.

B. Ahren, Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes, Nat Rev Drug Discov, vol.8, pp.369-385, 2009.

A. B. Goldfine and R. N. Kulkarni, Modulation of beta-cell function: a translational journey from the bench to the bedside, Diabetes Obes Metab, vol.14, issue.3, pp.152-160, 2012.

P. Gilon and J. C. Henquin, Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function, Endocr Rev, vol.22, pp.565-604, 2001.

B. Thorens, Brain glucose sensing and neural regulation of insulin and glucagon secretion, Diabetes Obes Metab, vol.13, issue.1, pp.82-88, 2011.

J. E. Campbell and D. J. Drucker, Pharmacology, physiology, and mechanisms of incretin hormone action, Cell Metab, vol.17, pp.819-837, 2013.

D. Gautam, S. J. Han, and A. Duttaroy, Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis, Diabetes Obes Metab, vol.9, issue.2, pp.158-169, 2007.

I. B. Leibiger, B. Leibiger, and P. O. Berggren, Insulin signaling in the pancreatic beta-cell, Annu Rev Nutr, vol.28, pp.233-251, 2008.

A. Assmann, C. Hinault, and R. N. Kulkarni, Growth factor control of pancreatic islet regeneration and function, Pediatr Diabetes, vol.10, pp.14-32, 2009.

M. Braun, R. Ramracheya, and P. Rorsman, Autocrine regulation of insulin secretion, Diabetes Obes Metab, vol.14, issue.3, pp.143-151, 2012.

L. Elghazi and E. Bernal-mizrachi, Akt and PTEN: beta-cell mass and pancreas plasticity, Trends Endocrinol Metab, vol.20, pp.243-251, 2009.

J. J. Kovacs, M. R. Hara, C. L. Davenport, J. Kim, and R. J. Lefkowitz, Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways, Dev Cell, vol.17, pp.443-458, 2009.

R. J. Lefkowitz and S. K. Shenoy, Transduction of receptor signals by beta-arrestins, Science, vol.308, pp.512-517, 2005.

L. M. Luttrell and D. Gesty-palmer, Beyond desensitization: physiological relevance of arrestin-dependent signaling, Pharmacol Rev, vol.62, pp.305-330, 2010.

S. M. Dewire, S. Ahn, R. J. Lefkowitz, and S. K. Shenoy, Beta-arrestins and cell signaling, Annu Rev Physiol, vol.69, pp.483-510, 2007.

E. J. Whalen, S. Rajagopal, and R. J. Lefkowitz, Therapeutic potential of beta-arrestin-and G protein-biased agonists, Trends Mol Med, vol.17, pp.126-139, 2011.

K. A. Defea, Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold?, Cell Signal, vol.23, pp.621-629, 2011.

C. J. Hupfeld and J. M. Olefsky, Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins, Annu Rev Physiol, vol.69, pp.561-577, 2007.

B. Luan, J. Zhao, and H. Wu, Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance, Nature, vol.457, pp.1146-1149, 2009.

J. Quoyer, C. Longuet, and C. Broca, GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic betacells, J Biol Chem, vol.285, pp.1989-2002, 2010.

N. Sonoda, T. Imamura, T. Yoshizaki, J. L. Babendure, J. C. Lu et al., Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells, Proc Natl Acad Sci, vol.105, pp.6614-6619, 2008.

J. Talbot, E. Joly, M. Prentki, and J. Buteau, beta-Arrestin1 mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic beta INS832/13 cells, Mol Cell Endocrinol, vol.354, pp.65-70, 2012.

C. Broca, J. Quoyer, and S. Costes, beta-Arrestin 1 is required for PAC1 receptormediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells, J Biol Chem, vol.284, pp.4332-4342, 2009.

K. C. Kong, A. J. Butcher, and P. Mcwilliams, M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1, Proc Natl Acad Sci, vol.107, pp.21181-21186, 2010.

S. Dalle, M. A. Ravier, and G. Bertrand, Emerging roles for beta-arrestin-1 in the control of the pancreatic beta-cell function and mass: new therapeutic strategies and consequences for drug screening, Cell Signal, vol.23, pp.522-528, 2011.

M. Zhang, Y. Zhu, and K. Mu, Loss of beta-arrestin2 mediates pancreatic-islet dysfunction in mice, Biochem Biophys Res Commun, vol.435, pp.345-349, 2013.

G. Bertrand, N. Ishiyama, M. Nenquin, M. A. Ravier, and J. C. Henquin, The elevation of glutamate content and the amplification of insulin secretion in glucose-stimulated pancreatic islets are not causally related, J Biol Chem, vol.277, pp.32883-32891, 2002.

S. E. Kahn, R. L. Hull, and K. M. Utzschneider, Mechanisms linking obesity to insulin resistance and type 2 diabetes, Nature, vol.444, pp.840-846, 2006.

M. M. Sachdeva and D. A. Stoffers, Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion, Mol Endocrinol, vol.23, pp.747-758, 2009.

C. A. Syme, L. Zhang, and A. Bisello, Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor, Mol Endocrinol, vol.20, pp.3400-3411, 2006.

R. Jorgensen, L. Martini, T. W. Schwartz, and C. E. Elling, Characterization of glucagonlike peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype, Mol Endocrinol, vol.19, pp.812-823, 2005.

R. Jorgensen, V. Kubale, M. Vrecl, T. W. Schwartz, and C. E. Elling, Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s), J Pharmacol Exp Ther, vol.322, pp.148-154, 2007.

D. Schelshorn, F. Joly, S. Mutel, C. Hampe, B. Breton et al., Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-proteincoupled receptor heteromer formation, Mol Pharmacol, vol.81, pp.309-318, 2012.

A. Eu, G. E. Lim, and A. E. Mehran, Pancreatic beta-cell Raf-1 is required for glucose tolerance, insulin secretion, and insulin 2 transcription, FASEB J, vol.25, pp.3884-3895, 2011.

C. Gu, G. H. Stein, and N. Pan, Pancreatic beta cells require NeuroD to achieve and maintain functional maturity, Cell Metab, vol.11, pp.298-310, 2010.

G. Meur, Q. Qian, S. Da, and G. Xavier, Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6), J Biol Chem, vol.286, pp.13647-13656, 2011.

Y. C. Lee and J. H. Nielsen, Regulation of beta cell replication, Mol Cell Endocrinol, vol.297, pp.18-27, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00532072

U. Gunasekaran, C. W. Hudgens, B. T. Wright, M. F. Maulis, and M. Gannon, Differential regulation of embryonic and adult beta cell replication, Cell Cycle, vol.11, pp.2431-2442, 2012.

B. Thorens, The required beta cell research for improving treatment of type 2 diabetes, J Intern Med, vol.274, pp.203-214, 2013.

J. Imai, H. Katagiri, and T. Yamada, Regulation of pancreatic beta cell mass by neuronal signals from the liver, Science, vol.322, pp.1250-1254, 2008.

A. El-ouaamari, D. Kawamori, and E. Dirice, Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states, Cell Rep, vol.3, pp.401-410, 2013.

P. Yi, J. S. Park, and D. A. Melton, Betatrophin: a hormone that controls pancreatic beta cell proliferation, Cell, vol.153, pp.747-758, 2013.

F. Buzzi, L. Xu, and R. A. Zuellig, Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass, Mol Cell Biol, vol.30, pp.601-612, 2010.